Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

CAPS Rating: 3 out of 5

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Recs

0
Player Avatar cyberccs (61.72) Submitted: 5/25/2009 5:33:24 AM : Outperform Start Price: $22.32 ONXX Score: +58.59

bullish

Report this Post Reply

Featured Broker Partners


Advertisement